Travis Mickle
Voorzitter bij KemPharm Denmark A/S
Vermogen: 254 110 $ op 30-04-2024
Profiel
Travis C.
Mickle was the founder of Zevra Therapeutics, Inc. founded in 2006, where he held the title of President & Director in 2023.
Currently, he is the Chairman at KemPharm Denmark A.
In the past, he worked as the Director-Drug Discovery & Chemical Development at New River Pharmaceuticals, Inc. from 2003 to 2005.
Dr. Mickle received his undergraduate degree from Simpson College in 1995 and his doctorate degree from the University of Iowa in 2000.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
ZEVRA THERAPEUTICS, INC.
0.13% | 22-03-2024 | 56 219 ( 0.13% ) | 254 110 $ | 30-04-2024 |
Actieve functies van Travis Mickle
| Bedrijven | Functie | Begin |
|---|---|---|
KemPharm Denmark A/S
 KemPharm Denmark A/S Miscellaneous Commercial ServicesCommercial Services Part of Zevra Therapeutics, Inc., KemPharm Denmark A/S is a Danish company that engages in the development of novel treatments for central nervous system. The company is based in Copenhagen, Denmark. The company was founded in 2022. The CEO is Raymond la Duane Clifton. | Voorzitter | 13-05-2022 |
Eerdere bekende functies van Travis Mickle
| Bedrijven | Functie | Einde |
|---|---|---|
| ZEVRA THERAPEUTICS, INC. | Algemeen Directeur | 25-04-2023 |
New River Pharmaceuticals, Inc.
 New River Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology New River Pharmaceuticals, Inc. develops pharmaceutical products. Its product candidates in clinical development are an amphetamine derivative (NDA filed) and an opioid derivative that they believe will provide alternatives to marketed drugs. The company was founded by Randal J. Kirk in 1996 and is headquartered in Radford, VA. | Corporate Officer/Principal | 01-10-2005 |
Opleiding van Travis Mickle
| University of Iowa | Doctorate Degree |
| Simpson College | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ZEVRA THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
New River Pharmaceuticals, Inc.
New River Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology New River Pharmaceuticals, Inc. develops pharmaceutical products. Its product candidates in clinical development are an amphetamine derivative (NDA filed) and an opioid derivative that they believe will provide alternatives to marketed drugs. The company was founded by Randal J. Kirk in 1996 and is headquartered in Radford, VA. | Health Technology |
KemPharm Denmark A/S
KemPharm Denmark A/S Miscellaneous Commercial ServicesCommercial Services Part of Zevra Therapeutics, Inc., KemPharm Denmark A/S is a Danish company that engages in the development of novel treatments for central nervous system. The company is based in Copenhagen, Denmark. The company was founded in 2022. The CEO is Raymond la Duane Clifton. | Commercial Services |